203 related articles for article (PubMed ID: 37762390)
1. The Human Ocular Surface Microbiome and Its Associations with the Tear Proteome in Dry Eye Disease.
Schlegel I; De Goüyon Matignon de Pontourade CMF; Lincke JB; Keller I; Zinkernagel MS; Zysset-Burri DC
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762390
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Ocular Surface Microbiome and Tear Proteome in Glaucoma.
Spörri L; Uldry AC; Kreuzer M; Herzog EL; Zinkernagel MS; Unterlauft JD; Zysset-Burri DC
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892444
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Interactions Between the Ocular Surface Microbiome and the Tear Proteome.
Zysset-Burri DC; Schlegel I; Lincke JB; Jaggi D; Keller I; Heller M; Lagache SB; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):8. PubMed ID: 34369983
[TBL] [Abstract][Full Text] [Related]
4. Ocular conjunctival microbiome profiling in dry eye disease: A case control pilot study.
Gupta N; Chhibber-Goel J; Gupta Y; Mukherjee S; Maitra A; Sharma A; Tandon R
Indian J Ophthalmol; 2023 Apr; 71(4):1574-1581. PubMed ID: 37026304
[TBL] [Abstract][Full Text] [Related]
5. Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease.
Liang Q; Li J; Zou Y; Hu X; Deng X; Zou B; Liu Y; Wei L; Liang L; Wen X
Front Cell Dev Biol; 2021; 9():731867. PubMed ID: 34900990
[No Abstract] [Full Text] [Related]
6. Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study?
Kuo MT; Fang PC; Kuo SF; Chen A; Huang YT
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401599
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
[TBL] [Abstract][Full Text] [Related]
8. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
[TBL] [Abstract][Full Text] [Related]
9. Ocular Surface Microbiota in Diabetic Patients With Dry Eye Disease.
Zhang Z; Zou X; Xue W; Zhang P; Wang S; Zou H
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):13. PubMed ID: 34524384
[TBL] [Abstract][Full Text] [Related]
10. Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients.
An Q; Zou H
Crit Rev Microbiol; 2023 Nov; 49(6):805-814. PubMed ID: 36409575
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of ocular surface status and function in primary Sjögren's syndrome with hypothyroidism].
Yu HZ; Zeng WZ; Wu WY; Yao ZQ; Feng Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):705-711. PubMed ID: 35950396
[TBL] [Abstract][Full Text] [Related]
12. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
[TBL] [Abstract][Full Text] [Related]
13. Ocular surface microbiota in patients with aqueous tear-deficient dry eye.
Andersson J; Vogt JK; Dalgaard MD; Pedersen O; Holmgaard K; Heegaard S
Ocul Surf; 2021 Jan; 19():210-217. PubMed ID: 32931939
[TBL] [Abstract][Full Text] [Related]
14. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
[TBL] [Abstract][Full Text] [Related]
15. Influence of Nasal Tear Osmolarity on Ocular Symptoms Related to Dry Eye Disease.
Yi HC; Lee YP; Shin YJ
Am J Ophthalmol; 2018 May; 189():71-76. PubMed ID: 29470972
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mucin levels at the ocular surface of visual display terminal users with and without dry eye disease.
Duan H; Yang T; Zhou Y; Ma B; Zhao L; Chen J; Qi H
BMC Ophthalmol; 2023 Apr; 23(1):189. PubMed ID: 37106448
[TBL] [Abstract][Full Text] [Related]
17. Assessing the ocular surface microbiome in severe ocular surface diseases.
Zilliox MJ; Gange WS; Kuffel G; Mores CR; Joyce C; de Bustros P; Bouchard CS
Ocul Surf; 2020 Oct; 18(4):706-712. PubMed ID: 32717380
[TBL] [Abstract][Full Text] [Related]
18. Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye.
Gumus K; Pflugfelder SC
Am J Ophthalmol; 2021 Jul; 227():35-44. PubMed ID: 33571473
[TBL] [Abstract][Full Text] [Related]
19. Ocular microbiome changes in dry eye disease and meibomian gland dysfunction.
Ozkan J; Majzoub ME; Coroneo M; Thomas T; Willcox M
Exp Eye Res; 2023 Oct; 235():109615. PubMed ID: 37586456
[TBL] [Abstract][Full Text] [Related]
20. Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium.
Ji YW; Kim HM; Ryu SY; Oh JW; Yeo A; Choi CY; Kim MJ; Song JS; Kim HS; Seo KY; Kim KP; Lee HK
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5035-5044. PubMed ID: 31800960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
